About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.
Forward Looking Statements
Statements contained in this press release regarding the Company's
intentions, hopes, beliefs, expectations, or predictions of the future are
"forward-looking'' statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements include the use of the PCT
SPS by the Brooklyn Hospital Center and the NYU School of Medicine, the
results of their studies having been presented at the Annual Scientific
Meeting of the American College of Gastroenterology. These statements are
based upon the Company's current expectations, forecasts, and assumptions
that are subject to risks, uncertainties, and other factors that could
cause actual outcomes and results to differ materially from those indicated
by these forward-looking statements. These risks, uncertainties, and other
factors include, but are not limited to: unforeseen technological
difficulties that the Company may encounter in the development of the PCT
technology and the PCT Sample Preparation System; the possibility that
other laboratories may be unable to duplicate the results generated by Dr.
Momeni and her colleagues; the possibility that the data generated may not
be beneficial in the development of new
|SOURCE Pressure BioSciences, Inc.|
Copyright©2007 PR Newswire.
All rights reserved